D014616Living BeingsB04.280.650.160.650.900B04.909.204.783.160.650.9006150.982794Vaccinia virusprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonBiochemistryMicrobiology and ImmunologyWake Forest School of MedicineDouglasLylesDouglas S. Lyles PhD36.08919100000000-80.26677800000000233Lyles, DouglasProfessorJasonGraysonJason M. Grayson PhD36.08977400000000-80.26684000000000419Grayson, JasonAssociate ProfessorMarthaAlexander-Miller4MC38pybvDqOTrPFxxARchSSnXEUZ/41PeKUY3jDi/Sa+yrfEF0=Martha A. Alexander-Miller PhD36.09032400000000-80.26649100000000603Alexander-Miller, MarthaProfessorMarlenaWestcottMarlena M. Westcott PhD36.09032400000000-80.26649100000000697Westcott, MarlenaAssociate ProfessorNancyKockNancy D. Kock DVM, PhD36.09040200000000-80.26700599999999717Kock, NancyProfessorPathology, Comparative Medicinetrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor20374000Delaney KN, Phipps JP, Johnson JB, Mizel SBViral immunologyDelaney KN, Phipps JP, Johnson JB, Mizel SB. A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice. Viral Immunol. 2010 Apr; 23(2):201-10.Viral Immunol2010-04-01T00:00:002010A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice.22706075Amoah S, Yammani RD, Grayson JM, Alexander-Miller MAJournal of immunology (Baltimore, Md. : 1950)Amoah S, Yammani RD, Grayson JM, Alexander-Miller MA. Changes in functional but not structural avidity during differentiation of CD8+ effector cells in vivo after virus infection. J Immunol. 2012 Jul 15; 189(2):638-45.J Immunol2012-06-15T00:00:002012Changes in functional but not structural avidity during differentiation of CD8+ effector cells in vivo after virus infection.23589620Amoah S, Holbrook BC, Yammani RD, Alexander-Miller MAJournal of immunology (Baltimore, Md. : 1950)Amoah S, Holbrook BC, Yammani RD, Alexander-Miller MA. High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion. J Immunol. 2013 May 15; 190(10):5020-9.J Immunol2013-04-15T00:00:002013High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion.20660207Beauchamp NM, Busick RY, Alexander-Miller MAJournal of virologyBeauchamp NM, Busick RY, Alexander-Miller MA. Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection. J Virol. 2010 Oct; 84(19):10191-9.J Virol2010-07-21T00:00:002010Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection.21885079Clark KM, Johnson JB, Kock ND, Mizel SB, Parks GDVirologyClark KM, Johnson JB, Kock ND, Mizel SB, Parks GD. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge. Virology. 2011 Oct 25; 419(2):97-106.Virology2011-08-31T00:00:002011Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.2.716730.01063266research area of0.4705840.04327515subject area for